CETP inhibition

被引：15

作者：

Duriez, Patrick ^{[1
]}

机构：

[1] INSERM, U545, F-59045 Lille, France

[2] Univ Law & Hlth, Fac Pharm, Physiol Lab, F-59006 Lille, France

来源：

LANCET | 2007年 / 370卷 / 9603期

关键词：

D O I：

10.1016/S0140-6736(07)61788-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1882 / 1883

页数：2

共 11 条

[1] Effects of torcetrapib in patients at high risk for coronary events [J].

Barter, Philip J. ;

Caulfield, Mark ;

Eriksson, Mats ;

Grundy, Scott M. ;

Kastelein, John J. P. ;

Komajda, Michel ;

Lopez-Sendon, Jose ;

Mosca, Lori ;

Tardif, Jean-Claude ;

Waters, David D. ;

Shear, Charles L. ;

Revkin, James H. ;

Buhr, Kevin A. ;

Fisher, Marian R. ;

Tall, Alan R. ;

Brewer, Bryan .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2109-2122

[2] Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial [J].

Bots, Michiel L. ;

Visseren, Frank L. ;

Evans, Gregory W. ;

Riley, Ward A. ;

Revkin, James H. ;

Tegeler, Charles H. ;

Shear, Charles L. ;

Duggan, William T. ;

Vicari, Ralph M. ;

Grobbee, Diederick E. ;

Kastelein, John J. .

LANCET, 2007, 370 (9582) :153-160

[3] Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion [J].

Brousseau, ME ;

Diffenderfer, MR ;

Millar, JS ;

Nartsupha, C ;

Asztalos, BF ;

Welty, FK ;

Wolfe, ML ;

Rudling, M ;

Björkhem, I ;

Angelin, B ;

Mancuso, JP ;

Digenio, AG ;

Rader, DJ ;

Schaefer, EJ .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) :1057-1064

[4]

COBAIN MR, 2007, AM J CARDIOL, V7, P623

[5] Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels [J].

Davidson, Michael H. ;

McKenney, James M. ;

Shear, Charles L. ;

Revkin, James H. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (09) :1774-1781

[6] Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia [J].

Kastelein, John J. P. ;

van Leuven, Sander I. ;

Burgess, Leslie ;

Evans, Greg W. ;

Kuivenhoven, Jan A. ;

Barter, Philip J. ;

Revkin, James H. ;

Grobbee, Diederick E. ;

Riley, Ward A. ;

Shear, Charles L. ;

Duggan, William T. ;

Bots, Michiel L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (16) :1620-1630

[7] Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies [J].

Krishna, Rajesh ;

Anderson, Matt S. ;

Bergman, Arthur J. ;

Jin, Bo ;

Fallon, Marissa ;

Cote, Josee ;

Rosko, Kim ;

Chavez-Eng, Cynthia ;

Lutz, Ryan ;

Bloomfield, Daniel M. ;

Gutierrez, Maria ;

Doherty, James ;

Bieberdorf, Fredrick ;

Chodakewitz, Jeffrey ;

Gottesdiener, Keith M. ;

Wagner, John A. .

LANCET, 2007, 370 (9603) :1907-1914

[8]

McKenney JM, 2006, J AM COLL CARDIOL, V48, P1782, DOI 10.1016/j.jacc.2006.06.066

[9] Effect of torcetrapib on the progression of coronary atherosclerosis [J].

Nissen, Steven E. ;

Tardif, Jean-Claude ;

Nicholls, Stephen J. ;

Revkin, James H. ;

Shear, Charles L. ;

Duggan, William T. ;

Ruzyllo, Witold ;

Bachinsky, William B. ;

Lasala, Gregory P. ;

Tuzcu, E. Murat .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13) :1304-1316

[10] High-density lipoprotein as a therapeutic target - A systematic review [J].

Singh, Inder M. ;

Shishehbor, Mehdi H. ;

Ansell, Benjamin J. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (07) :786-798

← 1 2 →